Published in Biotech Business Week, February 13th, 2006
Ron Steckel has been named chief operating officer of the company, while Richard Zimmer has been named vice president of sales. They replace David Martin and Bill Hoffman, respectively.
"Based on the new strategic initiatives we announced earlier this month, it is appropriate to effect this transition at this time," said John Simpson, interim chief executive officer. "I am delighted that we have two highly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.